ID

27317

Descripción

Antiestrogen vs Aromatase Inhibitor After Adjuvant Chemotherapy for Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00437359

Link

https://clinicaltrials.gov/show/NCT00437359

Palabras clave

Versiones (1)
  1. 8/11/17 8/11/17 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

8 de noviembre de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Breast Neoplasms NCT00437359

Inglés

Eligibility Breast Neoplasms NCT00437359

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
written consent obtained for study participation.
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
breast cancer diagnosed histologically with a breast removed or preserved.
Descripción

Breast Carcinoma | Mastectomy | Breast Preserved

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0678222
UMLS CUI [2]
C0024881
UMLS CUI [3,1]
C0006141
UMLS CUI [3,2]
C0033085
positive er or pr testing by immunohistochemistry (ihc), enzyme immunoassay (eia) and who meet the criteria of each institution.
Descripción

Estrogen receptor positive Immunohistochemistry | Progesterone receptor positive Immunohistochemistry | Estrogen receptor positive Enzyme Immunoassay | Progesterone receptor positive Enzyme Immunoassay

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0279754
UMLS CUI [1,2]
C0021044
UMLS CUI [2,1]
C0279759
UMLS CUI [2,2]
C0021044
UMLS CUI [3,1]
C0279754
UMLS CUI [3,2]
C0086231
UMLS CUI [4,1]
C0279759
UMLS CUI [4,2]
C0086231
her2 evaluation.
Descripción

HER2/Neu Status Evaluation

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1512413
UMLS CUI [1,2]
C1261322
patient status (ps): 0 or 1.
Descripción

Performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1518965
fully functional heart, liver, kidneys, and bone marrow.
Descripción

Cardiac function | Liver function | Renal function | Bone Marrow function

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0232164
UMLS CUI [2]
C0232741
UMLS CUI [3]
C0232804
UMLS CUI [4,1]
C0005953
UMLS CUI [4,2]
C0031843
more than one year since last menstruation or tested postmenopausal from estradiol (e2) and follicle-stimulating hormone (fsh) levels based on evaluation standard of each institution.
Descripción

Postmenopausal state Estradiol measurement | Postmenopausal state Follicle stimulating hormone measurement

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0232970
UMLS CUI [1,2]
C0337434
UMLS CUI [2,1]
C0232970
UMLS CUI [2,2]
C0202022
expected to live for at least three months (or longer) after study commencement.
Descripción

Life Expectancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023671
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnant or breast feeding.
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
bilateral or inflammatory breast cancer.
Descripción

Bilateral breast cancer | Inflammatory Breast Carcinoma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0281267
UMLS CUI [2]
C0278601
multiple cancers.
Descripción

Multiple malignancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0346429
life-threatening metastases.
Descripción

Neoplasm Metastasis Life Threatening

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0027627
UMLS CUI [1,2]
C2826244
history of serious hypersensitivity.
Descripción

Hypersensitivity Serious

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0205404
judged ineligible for the study by the study doctor.
Descripción

Ineligibility Clinical Trial

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1512714
UMLS CUI [1,2]
C0008976
Volver a la parte superior de la página

Similar models

Eligibility Breast Neoplasms NCT00437359

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
written consent obtained for study participation.
boolean
C0021430 (UMLS CUI [1])
Breast Carcinoma | Mastectomy | Breast Preserved
Item
breast cancer diagnosed histologically with a breast removed or preserved.
boolean
C0678222 (UMLS CUI [1])
C0024881 (UMLS CUI [2])
C0006141 (UMLS CUI [3,1])
C0033085 (UMLS CUI [3,2])
Estrogen receptor positive Immunohistochemistry | Progesterone receptor positive Immunohistochemistry | Estrogen receptor positive Enzyme Immunoassay | Progesterone receptor positive Enzyme Immunoassay
Item
positive er or pr testing by immunohistochemistry (ihc), enzyme immunoassay (eia) and who meet the criteria of each institution.
boolean
C0279754 (UMLS CUI [1,1])
C0021044 (UMLS CUI [1,2])
C0279759 (UMLS CUI [2,1])
C0021044 (UMLS CUI [2,2])
C0279754 (UMLS CUI [3,1])
C0086231 (UMLS CUI [3,2])
C0279759 (UMLS CUI [4,1])
C0086231 (UMLS CUI [4,2])
HER2/Neu Status Evaluation
Item
her2 evaluation.
boolean
C1512413 (UMLS CUI [1,1])
C1261322 (UMLS CUI [1,2])
Performance status
Item
patient status (ps): 0 or 1.
boolean
C1518965 (UMLS CUI [1])
Cardiac function | Liver function | Renal function | Bone Marrow function
Item
fully functional heart, liver, kidneys, and bone marrow.
boolean
C0232164 (UMLS CUI [1])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
C0005953 (UMLS CUI [4,1])
C0031843 (UMLS CUI [4,2])
Postmenopausal state Estradiol measurement | Postmenopausal state Follicle stimulating hormone measurement
Item
more than one year since last menstruation or tested postmenopausal from estradiol (e2) and follicle-stimulating hormone (fsh) levels based on evaluation standard of each institution.
boolean
C0232970 (UMLS CUI [1,1])
C0337434 (UMLS CUI [1,2])
C0232970 (UMLS CUI [2,1])
C0202022 (UMLS CUI [2,2])
Life Expectancy
Item
expected to live for at least three months (or longer) after study commencement.
boolean
C0023671 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Breast Feeding
Item
pregnant or breast feeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Bilateral breast cancer | Inflammatory Breast Carcinoma
Item
bilateral or inflammatory breast cancer.
boolean
C0281267 (UMLS CUI [1])
C0278601 (UMLS CUI [2])
Multiple malignancy
Item
multiple cancers.
boolean
C0346429 (UMLS CUI [1])
Neoplasm Metastasis Life Threatening
Item
life-threatening metastases.
boolean
C0027627 (UMLS CUI [1,1])
C2826244 (UMLS CUI [1,2])
Hypersensitivity Serious
Item
history of serious hypersensitivity.
boolean
C0020517 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
Ineligibility Clinical Trial
Item
judged ineligible for the study by the study doctor.
boolean
C1512714 (UMLS CUI [1,1])
C0008976 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial